Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21747099 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL20177060 | 0.93 | L3MBTL1 (0.40) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL22596487 | 0.92 | KDM4E (0.33) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL24125827 | 0.92 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL18561384 | 0.92 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL21365777 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL21365681 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL26041202 | 0.90 | CYP1A2 (0.38) | KDM4E | |
| SCHEMBL26040861 | 0.90 | CYP1A2 (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL27299772 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12035623-B2 | Organic molecules for optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| US-20210399230-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-12-23 | — | — | US | disclosed |
| WO-2020035365-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12035623-B2 | Organic molecules for optoelectronic devices | OR10J3, OR51E2, OCIAD2 | KDM4E 4589/4885ATM 3060/4885L3MBTL1 4438/4885 |
| US-20210399230-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, ORC3, OSTC | KDM4E 2563/4885ATM 3988/4885L3MBTL1 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.